Skip to content
PICO Portalanswers from OpenAlex

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

PaperCitations, authors & open-access status

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy is a paper indexed in PICO Portal from OpenAlex.

How many citations does Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy have?

PICO Portalcitation count

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy has 605 citations in the OpenAlex counts PICO Portal stores.

When was Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy published?

PICO Portalyear

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy has 2019 year in the PICO Portal index.

What is the open-access status of Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy?

PICO Portaloa status

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy has bronze oa status in the PICO Portal index.

What is the DOI of Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy?

PICO Portaldoi

The DOI for Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy is on the source record.

What is the PMID of Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy?

PICO Portalpmid

The PMID for Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy is on the source record.

What is the OpenAlex record for Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy?

PICO Portalopenalex

The OpenAlex for Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial